Edit |   |
---|---|
Antigenic Specificity | VEGFA, Human (Brolucizumab biosimilar) |
Clone | Brolucizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | scFv kappa-heavy |
Format | scFv fragment |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, IF, IP, FCM, Inhib |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human VEGFA Recombinant Antibody (Brolucizumab). Brolucizumab, sold under the trade name Beovu, is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). |
Immunogen | n/a |
Other Names | Anti-VEGFA Recombinant Antibody, Research Grade Brolucizumab, Anti-Human VEGFA Recombinant Antibody(Brolucizumab), ESBA-1008, ESBA1008, RTH258, Antibody Drug Analogues, Monoclonal Antibody, YR1363, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1531589-13-5 |
Catalog # | YR1363 |
Price | please inquire |
Order / More Info | VEGFA, Human (Brolucizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |